Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
KR20190034601A
Transdermal preparations and delivery methods of low solubility or unstable non-ionized neutral drugs by in situ conversion from salt drug to neutral drug of salt drug
AU2017281789A1
Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
MX2018008190A
Systems and methods for long term transdermal administration.
WO2017004067A1
Microarray for delivery of therapeutic agent, methods of use, and methods of making
EP3302422A1
Formulations for aripiprazole delivery transdermally
US2016135895A1
Medical device packaging
US2016067176A1
Microstructure array, methods of making, and methods of use
EP3193828A1
Microstructure array for delivery of active agents
WO2015042165A1
Topical adhesive composition, and device, for improving aesthetic appearance of skin
EP2968119A1
Microarray for delivery of therapeutic agent, methods of use, and methods of making
AU2014233695A1
Microarray for delivery of therapeutic agent and methods of use
CA2903763A1
Microarray with polymer-free microstructures, methods of making, and methods of use
EP2968751A2
Multiple impact microprojection applicators and methods of use
US2014276378A1
Microstructure array for delivery of active agents
EP2968887A1
Microprojection applicators
AU2014200648A1
Solvent-cast microneedle arrays containing active
AU2013364053A1
Microarray for delivery of therapeutic agent and methods of use
AU2011248108A1
Method and device for transdermal delivery of parathyroid hormone using a microprojection array
